Posted in | News

Harbinger Research Begins Research Coverage on China ACM

Oct 31 2009

China Advanced Construction Materials Group, Inc. ("China ACM") (OTC Bulletin Board: CADC), a leading provider of ready-mix concrete in China, today announced that Harbinger Research, LLC, an independent research firm, initiated research coverage on the company.

The coverage initiation report provides a description of China ACM's business, industry, products, strategy, management team, financial statements, and investment opportunities and risks. The report contains an investment rating and 12-month price target, and is available free of charge at Harbinger's website: http://www.harbingerresearch.com/link/16/246/CADC.

Harbinger Research was contracted by the Company to prepare the research report for the purpose of informing both institutional and individual investors of the investment potential of the Company. The price targets, financial projections and other opinions contained in the report are strictly those of the analyst and not of China Advanced Construction Materials Group.

Source: http://www.china-acm.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit
Reducing Embodied Carbon Through Design

Reducing Embodied Carbon Through Design

With an increase in the pressure to decarbonize the built environment and build more carbon-neutral buildings, the reduction of embodied carbon has become of great importance.

Calcium Carbonate Concrete: Building on Recycling

Calcium Carbonate Concrete: Building on Recycling

AZoBuild talks to Professors Noguchi and Maruyama about their research and development of Calcium Carbonate Concrete (CCC), a new material that has the potential to cause a sustainable revolution in the construction industry.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback